Nanoliposome as a carrier for topical delivery of oxymetazoline hydrochloride: In-vitro assessment and in-vivo anti-inflammatory potential

Banhishikha Kar , Beduin Mahanti , Ayan Kumar Kar , Subhabrota Majumdar

Intelligent Pharmacy ›› 2025, Vol. 3 ›› Issue (4) : 256 -267.

PDF (2992KB)
Intelligent Pharmacy ›› 2025, Vol. 3 ›› Issue (4) : 256 -267. DOI: 10.1016/j.ipha.2024.09.006
Full length article

Nanoliposome as a carrier for topical delivery of oxymetazoline hydrochloride: In-vitro assessment and in-vivo anti-inflammatory potential

Author information +
History +
PDF (2992KB)

Abstract

The present investigation on nanoliposome infused with oxymetazoline hydrochloride was fabricated with phosphatidylcholine and cholesterol to effectively deliver the drug to the skin. Oxymetazoline hydrochloride evidence to show anti-inflammatory characteristics. The drug produces pro-resolving lipoxins in accordance with the formation of anti-inflammatory 15(S)-hydroxy-eicosatetraenoic acid and the consequent reduction of proinflammatory lipid mediators such as leukotriene B4 which leads to the reduction in inflammation at the topical region. The oxymetazoline hydrochloride infused nanoliposomes were prepared by thin film lipid hydration method. The present research assessed the average particle size of different formulations ranges from 147.4±0.77 nm to 371.7±0.99 nm with polydispersity value ranging from 0.181±0.02 to 0.392±0.03. Furthermore, the zeta potentials ranging from -15.2±0.25 mV to -30.5±0.24 mV. The percentage of drug release at 12 h (Y1) has a p-value of 0.0073, entrapment efficiency (%) (Y2) has p-value of 0.0001 and particle size (nm) (Y3) has a p-value of 0.0480. Hence all the dependent responses found to be significant. This study exhibited small particle size distribution with consistent polydispersity index which ensure the monodispersed nature of the nanoliposomes. The satisfactory zeta potential value indicates the stability of formulation. The outcome of the study projected that oxymetazoline hydrochloride loaded nanoliposome have the potential to deliver drugs to specific regions with their high stability and predictable release at the target region.

Keywords

Oxymetazoline hydrochloride / Response surface methodology / Thin film lipid hydration / Anti-inflammatory activity / Nanostructured liposome

Cite this article

Download citation ▾
Banhishikha Kar, Beduin Mahanti, Ayan Kumar Kar, Subhabrota Majumdar. Nanoliposome as a carrier for topical delivery of oxymetazoline hydrochloride: In-vitro assessment and in-vivo anti-inflammatory potential. Intelligent Pharmacy, 2025, 3(4): 256-267 DOI:10.1016/j.ipha.2024.09.006

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Munir A , Palabiyik BB , Khan A , Shah A , Uslu B . A novel electrochemical method for the detection of oxymetazoline drug based on MWCNTs and TiO2 nanoparticles. J Electroanal Chem. 2019; 844: 58- 65.

[2]

Fei Liu MM , Qiujun Zhou MD , Hui Wang MM , et al. Efficacy and safety of oxymetazoline for the treatment of rosacea:a meta-analysis. J Cosmet Dermatol. 2023; 22: 2408- 2419.

[3]

Hmingthansanga V , Singh N , Banerjee S , Manickam S , Velayutham R , Natesan S . Improved topical drug delivery:role of permeation enhancers and advanced approaches. Pharmaceutics. 2022; 14 (12): 1- 31.

[4]

Tobias JD , Cartabuke R , Taghon T . Oxymetazoline (Afrin(R)):maybe there is more that we need to know. Paediatr Anaesth. 2014; 24 (8): 795- 798.

[5]

Majumdar S , Mahanti B , Kar AK , Parya H , Ghosh A , Nanoliposome Kar B . As a smart nanocarrier in transdermal drug delivery system. Intelligent Pharmacy. 2024: 1- 9.

[6]

Patel NU , Shukla S , Zaki J , Feldman SR . Oxymetazoline hydrochloride cream for facial erythema associated with rosacea. Expert Rev Clin Pharmacol. 2017; 10 (10): 1049- 1054.

[7]

Alem CMAv , Metselaar JM , Kooten Cv , Rotmans JI . Recent advances in liposomalbased anti-inflammatory therapy. Pharmaceutics. 2021; 13 (7): 1004:1- 100428.

[8]

Katz RI , Hovagim AR , Finkelstein HS , Grinberg Y , Boccio RV , Poppers PJ . A comparison of cocaine, lidocaine with epinephrine, and oxymetazoline for prevention of epistaxis on nasotracheal intubation. J Chromatogr, A. 1990; 2 (1): 16- 20.

[9]

Jana S , Manna S , Nayak AK , Sena KK , Basu SK . Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery. Colloids Surf B Biointerfaces. 2014; 114: 36- 44.

[10]

Krempl GA , Noorily AD . Use of oxymetazoline in the management of epistaxis. Ann Otol Rhinol Laryngol. 1995; 104 (9): 704- 706.

[11]

Zafar A , Yasir M , Panda DS , Singh L . Bergenin nano-lipid carrier to improve the oral delivery:development, optimization, in vitro and in vivo evaluation. J Drug Deliv Sci Technol. 2024; 96: 1- 15.

[12]

Phillips C , Blake MD , Huang CCMD . Topical oxymetazoline hydrochloride 0.05% as a strategy to reduce intraoperative wound oozing in mohs micrographic surgery. Dermatol Surg. 2015; 41 (6): 749- 750.

[13]

Ong SGM , Ming LC , Lee KS , Yuen KH . Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics. 2016; 8 (25): 1- 17.

[14]

Kar B , Mahanti B , Kar AK , Mazumder R , Roy A , Majumdar S . Nanoliposome enabled topical gel-based drug delivery system of ivermectin:fabrication, characterization, in-vivo and in -vitro investigation. Intelligent Pharmacy. 2024: 1- 11.

[15]

Majumdar S , Swain S , Rao MEB , Chakraborty P , Das SS . Acyclovir loaded solid lipid nanoparticulate gel for ocular delivery:optimization by using factorial design. IJPER. 2021; 55 (1s): s122- s134.

[16]

Sezer AD , Bas AL , Akbugaet J . Encapsulation of Enrofloxacin in Liposomes I:preparation and in vitro characterization of LUV. J Lipo Res. 2004; 14 (1,2): 77- 86.

[17]

Beukelman CJ , Berg AJJ , Hoekstra MJ , Uhl R , Reimer KMS . Anti-inflammatory properties of a liposomal hydrogel with povidone-iodine (Repithel) for wound healing in vitro. Burns. 2008; 34: 845- 855.

[18]

Majumdar S , Dey S , Ganguly D , Mazumder R . Enhanced topical permeability of natural flavonoid baicalein through nano liposomal gel:in vitro and in vivo investigation. J Drug Deliv Technol. 2020; 57: 101666.

[19]

Mazumder R , Mahanti B , Majumdar S , Pal R , Chowdhury AD . Response surface method for optimization of prepared satranidazole powder layered pellets. Futur J Pharm Sci. 2021; 190: 2- 11.

[20]

Sun S , Li B , Yang T , et al. Preparation, and evaluation of smart nanocarrier systems for drug delivery using magnetic nanoparticle and avidin-iminobiotin s system. J Nanomater. 2018: 1- 12.

[21]

Majumdar S , Roy S , Gupta R , Khatun N . Strategy for improving skin permeation by using topical nanoparticulate gel of Aloe Vera and In-Vivo evaluation using Wistar Rats. Der Pharm Sin. 2014; 5 (5): 42- 55.

[22]

Kar AK , Mahanti B , Kar B , et al. Development, optimization, and in-vivo bioavailability study of erlotinib hydrochloride loaded microsponge for colon targeting. Intelligent Pharmacy. 2024: 2- 10.

[23]

Kar AK , Shil A , Kar B , Dey S . Formulation development and statistical optimization of zingiberol incorporated sodium alginate-methyl cellulose blend microspheres. Int J Biol Macromol. 2020; 162: 1578- 1586.

[24]

Majumdar S , Mondal M , Bose A , Kar AK , Mazumder R . Fabrication, design, and in vivo investigation of mesoporous silica-based docetaxel trihydrate nanoparticles for colonic drug delivery. BNRC. 2023; 47: 142. 1- 142.16.

[25]

Mostafa M , Alaaeldin E , Aly UF , Sarhan H . Optimization and characterization of thymoquinone-loaded liposomes with enhanced topical anti-inflammatory activity. AAPS PharmSciTech. 2018: 1- 11.

[26]

Mazumder R , Mahanti B , Majumdar S , Pal R , Chowdhury AD . Improved comprehensive analytical method for assessment of satranidazole in drug and product. Futur J Pharm Sci. 2020; 6 (54): 1- 11.

[27]

Haeria A , Alinaghiana B , Daeihameda M , Dadashzadeh S . Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors. IJPR. 2013; 13: 3- 24.

[28]

Chen Y , Wu Q , Zhang Z , Yuan L , Liu X , Zhou L . Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012; 17: 5972- 5987.

[29]

Galvas DM , Simon O , Goracinova K . Formulation and characterization of topical liposomal gel bearing lidocaine HCl. Bull Chem Technol Macedonia. 2005; 24 (1): 59- 65.

[30]

Chatterjee S , Majumdar S , Mahanti B , Ganguly S . Potential paradigm of proteins and polypeptides-based nanostructures in drug delivery and management of maladies:a review. J Nanoparticle Res. 2024; 26 (4): 1- 11.

[31]

Sharma S , Shrestha B , Bhuyan NR , Majumdar S , Chowdhury S , Majumder R . Chemometric method development for the determination of naringin and verapamil. BNRC. 2024; 48 (13): 1- 12.

[32]

Paul S , Majumdar S , Chakraborty M . Revolutionizing ocular drug delivery:recent advancements in in situ gel technology. BNRC. 2023; 47 (154): 1- 13.

[33]

Majumdar S , Roy S , Choudhury S . Preparation, and gamma scintigraphic evaluation of colon specific pellets of ketoprofen prepared by powder layering technology. DARU J Pharm Sci. 2011; 19 (1): 47- 56.

[34]

Majumdar S , Roy S , Ghosh B . Design and gamma scintigraphic evaluation of colon specific pectin-EC pellets of secnidazole prepared by powder layering technology. Pharmazie. 2011; 66 (11): 843- 848.

[35]

Dey S , Majumdar S , Hasnain S , Nayak AK . Cross-linking of chitosan in drug delivery. Chitosan in Drug Delivery. 2022: 277- 299.

RIGHTS & PERMISSIONS

The Authors. Publishing services by Elsevier B.V. on behalf of Higher Education Press and KeAi Communications Co. Ltd.

AI Summary AI Mindmap
PDF (2992KB)

283

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/